Mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC

Yi-Ting Liu,Danielle A. Sliter,Mario K. Shammas,Xiaoping Huang,Chunxin Wang,Hannah Calvelli,Dragan S. Maric,Derek P. Narendra
DOI: https://doi.org/10.1080/15548627.2021.1896924
IF: 13.391
2021-03-08
Autophagy
Abstract:PINK1 and PRKN, which cause Parkinson disease when mutated, form a quality control mitophagy pathway that is well-characterized in cultured cells. The extent to which the PINK1-PRKN pathway contributes to mitophagy in vivo, however, is controversial. This is due in large part to conflicting results from studies using one of two mitophagy reporters: mt-Keima or mito-QC. Studies using mt-Keima have generally detected PINK1-PRKN mitophagy in vivo, whereas those using mito-QC generally have not. Here, we directly compared the performance of mito-QC and mt-Keima in cell culture and in mice subjected to a PINK1-PRKN activating stress. We found that mito-QC was less sensitive than mt-Keima for mitophagy, and that this difference was more pronounced for PINK1-PRKN mitophagy. These findings suggest that mito-QC's poor sensitivity may account for conflicting reports of PINK1-PRKN mitophagy in vivo and caution against using mito-QC as a reporter for PINK1-PRKN mitophagy.
cell biology
What problem does this paper attempt to address?